About Visunex
Visunex is a Healthcare company based in Fremont (United States) founded in 2013. Developer of devices for the pediatric ophthalmic market. Visunex has raised $43.7 million across 3 funding rounds from investors including BioVeda China Fund. Its chief executive, as recorded, is Wei Su. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Imaging.
Company details
Visunex Medical Systems develops devices for the pediatric ophthalmic market. Products developed by the company include PanoCam LT (a wide-field digital imaging system combined with information systems), PanoCam Pro ( a tool to aid in the screening, diagnosis, and management of pediatric and retinal vision disorders), PanoCam Review Station (fully DICOM compatible, patient data and images can be shared and viewed from anywhere), Visunex Cloud Management System, and PanoCam Newborn Nest (examination table).
- Headquarters Fremont, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website visunex.com
- Social LinkedIn X Facebook
- Total Equity Funding$43.7M (USD)
in 3 rounds
- Latest Funding Round$20M (USD), Series B
May 2017
- Investors
Funding Insights of Visunex
Visunex has successfully raised a total of $43.7M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $43.7M
- Total Rounds 3
- Last Round Series B — $20M
- First Round $3.7M
(Jun 2013)
- Investors Count 1
All 3 funding rounds of Visunex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2017 | $20M | Series B | – | – | – |
| Apr 2017 | $20M | Series B | – | – | – |
| Jun 2013 | $3.7M | Series A | – | – |
1 investors in total: 1 institutional.
Investors in Visunex
Visunex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BioVeda China Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm funding companies in China and the US | bvcf.com | Huangpu, China |
Investor details for Visunex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Visunex
1 people are tracked at Visunex (1 in leadership).
| Name | Role | Group |
|---|---|---|
Wei Su | CEO | Leadership |
Complete people profiles for Visunex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Visunex
3 dated milestones of Visunex across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Visunex is founded.
- Funding First funding round of $3.7M.
- Funding Latest funding round, Series B, of $20.0M.
Web traffic of Visunex
The website of Visunex (visunex.com) receives about 1K visits a month.
- Monthly visits1K
▲ 108.1% vs previous month
Top companies in Ophthalmology
3 companies that operate in the same segment as Visunex (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Visunex
Visunex was founded in 2013.
Visunex is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Wei Su is the CEO of Visunex, as recorded in our data.
Visunex is a funded company, having raised a total of $43.7M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.7M, raised on Jun 2013.
Visunex Medical Systems develops devices for the pediatric ophthalmic market. Products developed by the company include PanoCam LT (a wide-field digital imaging system combined with information systems), PanoCam Pro ( a tool to aid in the screening, diagnosis, and management of pediatric and retinal vision disorders), PanoCam Review Station (fully DICOM compatible, patient data and images can be shared and viewed from anywhere), Visunex Cloud Management System, and PanoCam Newborn Nest (examination table).
Visunex has 1 investor. Key investors include BioVeda China Fund.